A citation-based method for searching scientific literature


List of co-cited articles
944 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
C Orskov, L Rabenhøj, A Wettergren, H Kofod, J J Holst. Diabetes 1994
711
44

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
26

Role of glucagon in maintenance of euglycemia in fed and fasted rats.
C L Brand, P N Jørgensen, U Knigge, J Warberg, I Svendsen, J S Kristensen, J J Holst. Am J Physiol 1995
73
23

Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
Ola Lindgren, Richard D Carr, Carolyn F Deacon, Jens J Holst, Giovanni Pacini, Andrea Mari, Bo Ahrén. J Clin Endocrinol Metab 2011
121
15

Glucose sensing in L cells: a primary cell study.
Frank Reimann, Abdella M Habib, Gwen Tolhurst, Helen E Parker, Gareth J Rogers, Fiona M Gribble. Cell Metab 2008
510
13

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
13


Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
T Vilsbøll, T Krarup, J Sonne, S Madsbad, A Vølund, A G Juul, J J Holst. J Clin Endocrinol Metab 2003
363
11

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
11


Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.
Jesper Gromada, Isobel Franklin, Claes B Wollheim. Endocr Rev 2007
398
11


Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M A Nauck, I Vardarli, C F Deacon, J J Holst, J J Meier. Diabetologia 2011
303
10

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
M B Toft-Nielsen, M B Damholt, S Madsbad, L M Hilsted, T E Hughes, B K Michelsen, J J Holst. J Clin Endocrinol Metab 2001
617
10



Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes.
Jens J Holst, Filip K Knop, Tina Vilsbøll, Thure Krarup, Sten Madsbad. Diabetes Care 2011
172
10

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
M Nauck, F Stöckmann, R Ebert, W Creutzfeldt. Diabetologia 1986
873
10

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.
Gwen Tolhurst, Helen Heffron, Yu Shan Lam, Helen E Parker, Abdella M Habib, Eleftheria Diakogiannaki, Jennifer Cameron, Johannes Grosse, Frank Reimann, Fiona M Gribble. Diabetes 2012
977
10


Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?
Nicolai J Wewer Albrechtsen, Bolette Hartmann, Simon Veedfald, Johanne A Windeløv, Astrid Plamboeck, Kirstine N Bojsen-Møller, Thomas Idorn, Bo Feldt-Rasmussen, Filip K Knop, Tina Vilsbøll,[...]. Diabetologia 2014
118
10

Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Christine Longuet, Ana M Robledo, E Danielle Dean, Chunhua Dai, Safina Ali, Ian McGuinness, Vincent de Chavez, Patricia M Vuguin, Maureen J Charron, Alvin C Powers,[...]. Diabetes 2013
114
10

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
R W Gelling, X Q Du, D S Dichmann, J Romer, H Huang, L Cui, S Obici, B Tang, J J Holst, C Fledelius,[...]. Proc Natl Acad Sci U S A 2003
375
10

Evidence of Extrapancreatic Glucagon Secretion in Man.
Asger Lund, Jonatan I Bagger, Nicolai J Wewer Albrechtsen, Mikkel Christensen, Magnus Grøndahl, Bolette Hartmann, Elisabeth R Mathiesen, Carsten P Hansen, Jan H Storkholm, Gerrit van Hall,[...]. Diabetes 2016
94
10

Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Richard D Carr, Marianne O Larsen, Maria Sörhede Winzell, Katarina Jelic, Ola Lindgren, Carolyn F Deacon, Bo Ahrén. Am J Physiol Endocrinol Metab 2008
127
9

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Kirsten Vollmer, Jens J Holst, Birgit Baller, Mark Ellrichmann, Michael A Nauck, Wolfgang E Schmidt, Juris J Meier. Diabetes 2008
238
9

The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.
Kristine J Hare, Tina Vilsbøll, Meena Asmar, Carolyn F Deacon, Filip K Knop, Jens J Holst. Diabetes 2010
168
9


GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines.
Rune Ehrenreich Kuhre, Nicolai Wewer Albrechtsen, Johanne Agerlin Windeløv, Berit Svendsen, Bolette Hartmann, Jens Juul Holst. Peptides 2014
41
21

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Filip K Knop, K Aaboe, T Vilsbøll, A Vølund, J J Holst, T Krarup, S Madsbad. Diabetes Obes Metab 2012
109
9

Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine.
Rune E Kuhre, Charlotte R Frost, Berit Svendsen, Jens J Holst. Diabetes 2015
95
9



Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
Elza Muscelli, Andrea Mari, Arturo Casolaro, Stefania Camastra, Giuseppe Seghieri, Amalia Gastaldelli, Jens J Holst, Ele Ferrannini. Diabetes 2008
255
8


Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.
Mikkel Christensen, Louise Vedtofte, Jens J Holst, Tina Vilsbøll, Filip K Knop. Diabetes 2011
177
8

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.
S Calanna, M Christensen, J J Holst, B Laferrère, L L Gluud, T Vilsbøll, F K Knop. Diabetologia 2013
147
8

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies.
M J Bak, N J Wewer Albrechtsen, J Pedersen, F K Knop, T Vilsbøll, N B Jørgensen, B Hartmann, C F Deacon, L O Dragsted, J J Holst. Diabetes Obes Metab 2014
57
14



Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Valentin Gorboulev, Annette Schürmann, Volker Vallon, Helmut Kipp, Alexander Jaschke, Dirk Klessen, Alexandra Friedrich, Stephan Scherneck, Timo Rieg, Robyn Cunard,[...]. Diabetes 2012
405
7



TGR5-mediated bile acid sensing controls glucose homeostasis.
Charles Thomas, Antimo Gioiello, Lilia Noriega, Axelle Strehle, Julien Oury, Giovanni Rizzo, Antonio Macchiarulo, Hiroyasu Yamamoto, Chikage Mataki, Mark Pruzanski,[...]. Cell Metab 2009
7



Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
R Eissele, R Göke, S Willemer, H P Harthus, H Vermeer, R Arnold, B Göke. Eur J Clin Invest 1992
449
7

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
C Dirksen, N B Jørgensen, K N Bojsen-Møller, U Kielgast, S H Jacobsen, T R Clausen, D Worm, B Hartmann, J F Rehfeld, M Damgaard,[...]. Int J Obes (Lond) 2013
161
7

Circulating glucagon after total pancreatectomy in man.
J J Holst, J H Pedersen, F Baldissera, F Stadil. Diabetologia 1983
74
9

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Asger Lund, Tina Vilsbøll, Jonatan I Bagger, Jens J Holst, Filip K Knop. Am J Physiol Endocrinol Metab 2011
102
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.